Toolkit
Latest project information
HTA - 13/07/01
The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171) [ID667]
Project title: The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171) [ID667]
Call to action: 14/87 Batch 29
Research type: Evidence Synthesis
Chief investigator: Professor Chris Hyde
Contractor: University of Exeter
Cost: £153,125.00
Started: November 2013 | Status: Project complete
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research